Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
64.29B | 64.78B | 65.83B | 66.58B | 59.08B | 63.57B | Gross Profit |
16.93B | 15.72B | 17.46B | 19.27B | 18.06B | 19.16B | EBIT |
272.00M | -939.00M | 766.00M | 2.35B | 2.34B | 1.94B | EBITDA |
4.19B | 1.55B | 4.21B | 5.64B | 5.38B | 4.58B | Net Income Common Stockholders |
-22.00M | -2.31B | 365.00M | 1.31B | 1.17B | 829.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.86B | 5.16B | 4.55B | 5.48B | 8.38B | 6.61B | Total Assets |
102.58B | 101.75B | 97.02B | 95.06B | 91.14B | 80.69B | Total Debt |
40.67B | 39.72B | 36.60B | 33.64B | 35.62B | 30.92B | Net Debt |
35.81B | 34.55B | 32.06B | 28.16B | 27.25B | 24.31B | Total Liabilities |
57.24B | 57.04B | 52.62B | 50.88B | 50.02B | 44.19B | Stockholders Equity |
44.46B | 43.86B | 43.35B | 43.15B | 40.23B | 35.81B |
Cash Flow | Free Cash Flow | ||||
0.00 | -933.00M | -3.34B | 940.00M | -960.00M | 1.40B | Operating Cash Flow |
0.00 | 4.03B | 109.00M | 4.60B | 4.09B | 4.04B | Investing Cash Flow |
0.00 | -5.07B | -2.94B | -3.92B | -5.27B | -303.00M | Financing Cash Flow |
0.00 | 1.53B | 1.94B | -3.80B | 2.83B | -740.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥24.72B | 14.06 | 4.63% | 1.57% | 20.22% | ||
72 Outperform | ¥5.87B | 58.09 | 2.47% | 4.82% | -89.34% | ||
65 Neutral | ¥8.33B | 8.05 | 3.73% | 8.65% | 84.06% | ||
65 Neutral | ¥7.70B | 4.32 | 2.91% | 0.58% | ― | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
55 Neutral | ¥7.84B | 117.73 | 5.64% | 2.17% | -101.54% | ||
52 Neutral | ¥9.90B | 3.86 | 4.46% | -0.65% | -100.90% |